JILL FERRY: Open Payments
NPI 1588772685 · HARLAN, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 53 payments from 17 companies in 2025. Trend: 2023 $302 · 2024 $294 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $251 |
| Novo Nordisk Inc | 10 | $209 |
| AstraZeneca Pharmaceuticals LP | 6 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| PFIZER INC. | 2 | $53 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $46 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $22 |
Products named: MOUNJARO, Ozempic, LEQVIO, PREVNAR 20, Wegovy, Rybelsus, JOURNAVX, KOSELUGO.
Industry payments across IA — which companies pay providers there.
